{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:24:45Z","timestamp":1792189485398,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T00:00:00Z","timestamp":1479945600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00415-016-8346-2","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T10:10:44Z","timestamp":1479982244000},"page":"1292-1297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Neuroborreliosis"],"prefix":"10.1007","volume":"264","author":[{"given":"John J.","family":"Halperin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,24]]},"reference":[{"key":"8346_CR1","first-page":"765","volume":"71","author":"C Garin","year":"1922","unstructured":"Garin C, Bujadoux A (1922) Paralysie par les tiques. J Med Lyon 71:765\u2013767","journal-title":"J Med Lyon"},{"key":"8346_CR2","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/WNL.40.9.1340","volume":"40","author":"JJ Halperin","year":"1990","unstructured":"Halperin JJ, Krupp LB, Golightly MG, Volkman DJ (1990) Lyme borreliosis-associated encephalopathy. Neurology 40:1340\u20131343","journal-title":"Neurology"},{"issue":"6","key":"8346_CR3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/cid\/cir464","volume":"53","author":"JA Branda","year":"2011","unstructured":"Branda JA, Linskey K, Kim YA, Steere AC, Ferraro MJ (2011) Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay. Clin Infect Dis 53(6):541\u2013547","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8346_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diagmicrobio.2012.09.003","volume":"75","author":"GP Wormser","year":"2013","unstructured":"Wormser GP, Schriefer M, Aguero-Rosenfeld ME et al (2013) Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Diagn Microbiol Infect Dis 75(1):9\u201315","journal-title":"Diagn Microbiol Infect Dis"},{"key":"8346_CR5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/brain\/115.2.399","volume":"115","author":"K Hansen","year":"1992","unstructured":"Hansen K, Lebech AM (1992) The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985\u20131990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain 115:399\u2013423","journal-title":"Brain"},{"issue":"5","key":"8346_CR6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/JCM.21.5.819-825.1985","volume":"21","author":"GT Stiernstedt","year":"1985","unstructured":"Stiernstedt GT, Granstrom M, Hederstedt B, Skoldenberg B (1985) Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J Clin Microbiol 21(5):819\u2013825","journal-title":"J Clin Microbiol"},{"issue":"4","key":"8346_CR7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s00415-011-6221-8","volume":"259","author":"M Djukic","year":"2012","unstructured":"Djukic M, Schmidt-Samoa C, Lange P et al (2012) Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis. J Neurol 259(4):630\u2013636","journal-title":"J Neurol"},{"key":"8346_CR8","doi-asserted-by":"crossref","unstructured":"Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17(1):8\u201316 (e1\u2013e4)","DOI":"10.1111\/j.1468-1331.2009.02862.x"},{"issue":"3","key":"8346_CR9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/ciw299","volume":"63","author":"K Ogrinc","year":"2016","unstructured":"Ogrinc K, Lusa L, Lotric-Furlan S et al (2016) Course and outcome of early European Lyme Neuroborreliosis (Bannwarth Syndrome): clinical and laboratory findings. Clin Infect Dis 63(3):346\u2013353","journal-title":"Clin Infect Dis"},{"issue":"3","key":"8346_CR10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/01.wnl.0000171349.06645.79","volume":"65","author":"TA Rupprecht","year":"2005","unstructured":"Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B, Koedel U (2005) The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 65(3):448\u2013450","journal-title":"Neurology"},{"issue":"5","key":"8346_CR11","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00415-008-0785-y","volume":"255","author":"U Ljostad","year":"2008","unstructured":"Ljostad U, Mygland A (2008) CSF B\u2013lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol 255(5):732\u2013737","journal-title":"J Neurol"},{"issue":"3","key":"8346_CR12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.jnen.0000248556.30209.6d","volume":"66","author":"H Gelderblom","year":"2007","unstructured":"Gelderblom H, Londono D, Bai Y et al (2007) High production of CXCL13 in blood and brain during persistent infection with the relapsing fever spirochete Borrelia turicatae. J Neuropathol Exp Neurol 66(3):208\u2013217","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"8346_CR13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/OLQ.0b013e3181d877a1","volume":"37","author":"CM Marra","year":"2010","unstructured":"Marra CM, Tantalo LC, Sahi SK, Maxwell CL, Lukehart SA (2010) CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis. Sex Transm Dis 37(5):283\u2013287","journal-title":"Sex Transm Dis"},{"key":"8346_CR14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1742-2094-9-93","volume":"9","author":"MC Kowarik","year":"2012","unstructured":"Kowarik MC, Cepok S, Sellner J et al (2012) CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation. J Neuroinflammation 9:93","journal-title":"J Neuroinflammation"},{"issue":"1","key":"8346_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12987-015-0008-8","volume":"12","author":"R Dersch","year":"2015","unstructured":"Dersch R, Hottenrott T, Senel M et al (2015) The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis. Fluids Barriers CNS 12(1):1\u20135","journal-title":"Fluids Barriers CNS"},{"key":"8346_CR16","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/brain\/113.4.1207","volume":"113","author":"JJ Halperin","year":"1990","unstructured":"Halperin JJ, Luft BJ, Volkman DJ, Dattwyler RJ (1990) Lyme neuroborreliosis\u2014peripheral nervous system manifestations. Brain 113:1207\u20131221","journal-title":"Brain"},{"issue":"3","key":"8346_CR17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ana.410410313","volume":"41","author":"JD England","year":"1997","unstructured":"England JD, Bohm RP, Roberts ED, Philipp MT (1997) Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann Neurol 41(3):375\u2013384","journal-title":"Ann Neurol"},{"issue":"12","key":"8346_CR18","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00234-005-1440-2","volume":"47","author":"P Kalina","year":"2005","unstructured":"Kalina P, Decker A, Kornel E, Halperin JJ (2005) Lyme disease of the brainstem. Neuroradiology 47(12):903\u2013907","journal-title":"Neuroradiology"},{"issue":"5","key":"8346_CR19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0887-8994(97)00215-4","volume":"18","author":"L Kan","year":"1998","unstructured":"Kan L, Sood SK, Maytal J (1998) Pseudotumor cerebri in Lyme disease: a case report and literature review. Pediatr Neurol 18(5):439\u2013441","journal-title":"Pediatr Neurol"},{"issue":"7","key":"8346_CR20","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.amjmed.2008.02.032","volume":"121","author":"JE Castaldo","year":"2008","unstructured":"Castaldo JE, Griffith E, Monkowski DH (2008) Pseudotumor cerebri: early manifestation of adult Lyme disease. Am J Med 121(7):e5\u2013e6","journal-title":"Am J Med"},{"issue":"21","key":"8346_CR21","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","volume":"323","author":"EL Logigian","year":"1990","unstructured":"Logigian EL, Kaplan RF, Steere AC (1990) Chronic neurologic manifestations of Lyme disease. N Engl J Med 323(21):1438\u20131444","journal-title":"N Engl J Med"},{"key":"8346_CR22","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1212\/WNL.41.10.1571","volume":"41","author":"JJ Halperin","year":"1991","unstructured":"Halperin JJ, Volkman DJ, Wu P (1991) Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 41:1571\u20131582","journal-title":"Neurology"},{"issue":"11","key":"8346_CR23","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/01.mlr.0000182493.57090.c1","volume":"43","author":"N Luo","year":"2005","unstructured":"Luo N, Johnson J, Shaw J, Feeny D, Coons S (2005) Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care 43(11):1078\u20131086","journal-title":"Med Care"},{"issue":"6","key":"8346_CR24","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/432733","volume":"192","author":"MS Klempner","year":"2005","unstructured":"Klempner MS, Wormser GH, Wade K et al (2005) A case-control study to examine HLA haplotype associations in patients with posttreatment chronic Lyme disease. J Infect Dis 192(6):1010\u20131013","journal-title":"J Infect Dis"},{"issue":"8","key":"8346_CR25","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-121-8-199410150-00002","volume":"121","author":"NA Shadick","year":"1994","unstructured":"Shadick NA, Phillips CB, Logigian EL et al (1994) The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med 121(8):560\u2013567","journal-title":"Ann Intern Med"},{"issue":"2","key":"8346_CR26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","volume":"345","author":"MS Klempner","year":"2001","unstructured":"Klempner MS, Hu LT, Evans J et al (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345(2):85\u201392","journal-title":"N Engl J Med"},{"issue":"12","key":"8346_CR27","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","volume":"60","author":"LB Krupp","year":"2003","unstructured":"Krupp LB, Hyman LG, Grimson R et al (2003) Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 60(12):1923\u20131930","journal-title":"Neurology"},{"key":"8346_CR28","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","volume":"70","author":"BA Fallon","year":"2008","unstructured":"Fallon BA, Keilp JG, Corbera KM et al (2008) A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 70:992\u20131003","journal-title":"Neurology"},{"issue":"13","key":"8346_CR29","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa1505425","volume":"374","author":"A Berende","year":"2016","unstructured":"Berende A, ter Hofstede HJ, Vos FJ et al (2016) Randomized trial of longer-term therapy for symptoms attributed to Lyme disease. N Engl J Med 374(13):1209\u20131220","journal-title":"N Engl J Med"},{"issue":"1","key":"8346_CR30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1468-1331.2009.02756.x","volume":"17","author":"U Ljostad","year":"2009","unstructured":"Ljostad U, Mygland A (2009) Remaining complaints 1\u00a0year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors. Eur J Neurol 17(1):118\u2013123","journal-title":"Eur J Neurol"},{"issue":"3","key":"8346_CR31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0404.2012.01690.x","volume":"127","author":"R Eikeland","year":"2013","unstructured":"Eikeland R, Mygland A, Herlofson K, Ljostad U (2013) Risk factors for a non-favorable outcome after treated European neuroborreliosis. Acta Neurol Scand 127(3):154\u2013160","journal-title":"Acta Neurol Scand"},{"issue":"11","key":"8346_CR32","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1007\/s00415-015-7891-4","volume":"262","author":"R Dersch","year":"2015","unstructured":"Dersch R, Sarnes AA, Maul M et al (2015) Quality of life, fatigue, depression and cognitive impairment in Lyme neuroborreliosis. J Neurol 262(11):2572\u20132577","journal-title":"J Neurol"},{"issue":"1","key":"8346_CR33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00415-015-7923-0","volume":"263","author":"R Dersch","year":"2016","unstructured":"Dersch R, Sommer H, Rauer S, Meerpohl JJ (2016) Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review. J Neurol 263(1):17\u201324","journal-title":"J Neurol"},{"issue":"12","key":"8346_CR34","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/cid\/ciw189","volume":"62","author":"AB Wills","year":"2016","unstructured":"Wills AB, Spaulding AB, Adjemian J et al (2016) Long-term follow-up of patients with Lyme disease: longitudinal analysis of clinical and quality-of-life measures. Clin Infect Dis 62(12):1546\u20131551","journal-title":"Clin Infect Dis"},{"issue":"5","key":"8346_CR35","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.283.5.609","volume":"283","author":"EG Seltzer","year":"2000","unstructured":"Seltzer EG, Gerber MA, Cartter ML, Freudigman K, Shapiro ED (2000) Long-term outcomes of persons with Lyme disease. JAMA 283(5):609\u2013616","journal-title":"JAMA"},{"issue":"2","key":"8346_CR36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.amjmed.2014.09.022","volume":"128","author":"GP Wormser","year":"2015","unstructured":"Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Nowakowski J (2015) Long-term assessment of fatigue in patients with culture-confirmed Lyme disease. Am J Med 128(2):181\u2013184","journal-title":"Am J Med"},{"issue":"4","key":"8346_CR37","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0022-3476(05)83541-3","volume":"122","author":"JC Salazar","year":"1993","unstructured":"Salazar JC, Gerber MA, Goff CW (1993) Long-term outcome of Lyme disease in children given early treatment. J Pediatr 122(4):591\u2013593","journal-title":"J Pediatr"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-016-8346-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8346-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8346-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T19:26:32Z","timestamp":1657826792000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-016-8346-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,24]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["8346"],"URL":"https:\/\/doi.org\/10.1007\/s00415-016-8346-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,24]]}}}